Citizens Jmp upgraded shares of Quince Therapeutics (NASDAQ:QNCX – Free Report) from a market perform rating to an outperform rating in a research note issued to investors on Tuesday morning, Marketbeat.com reports. They currently have $77.00 price objective on the stock. Several other research firms have also commented on QNCX. Craig Hallum upgraded Quince Therapeutics […]